Modeling human cancer cachexia in colon 26 tumor-bearing adult mice

Journal of Cachexia, Sarcopenia and Muscle

Volumn 5, Issue 4, 2014, Pages 321-328

  Talbert, Erin E ^a   Metzger, Gregory A ^a   He, Wei A ^a   Guttridge, Denis C ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Autophagy; Muscle regeneration; Muscle wasting; Ubiquitin ligases

Indexed keywords

IMMUNOGLOBULIN G; INTERLEUKIN 6; UBIQUITIN PROTEIN LIGASE;

ADULT; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BODY MASS; CACHEXIA; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; MOUSE; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE REGENERATION; NONHUMAN; PROTEIN DEGRADATION; QUADRICEPS FEMORIS MUSCLE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; TUMOR CELL INOCULATION; TUMOR GROWTH; TUMOR VOLUME; WEIGHT REDUCTION;

EID: 84951559604     PISSN: 21905991     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13539-014-0141-2     Document Type: Article

References (28)

1. Tsoli M, Robertson G. Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem. Trends Endocrinol Metab. 2013;24:174–83.
2. Fearon K, Glass D, Guttridge D. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 2012;16:153–66.
3. Tisdale M. Tumor-host interactions. J Cell Biochem. 2004;93:871–7.
4. Andreyev HJ, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer. 1998;34:503–9.
5. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev. 2009;89:381–410.
6. Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, Swoap S, et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest. 2004;114:370–8.
7. He WA, Berardi E, Cardillo VM, Acharyya S, Aulino P, Thomas-Ahner J et al. NF-kappaB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest. 2013;123:4821–35.
8. Acharyya S, Butchbach ME, Sahenk Z, Wang H, Saji M, Carathers M, et al. Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell. 2005;8:421–32.
9. Murphy K, Chee A, Trieu J, Naim T, Lynch G. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia. Dis Model Mech. 2012;5:533–45.
10. Tanaka M, Miyazaki H, Takeda Y, Takeo S. Detection of serum cytokine levels in experimental cancer cachexia of colon 26 adenocarcinoma-bearing mice. Cancer Lett. 1993;72:65–70.
11. Tanaka Y, Eda H, Tanaka T, Udagawa T, Ishikawa T, Horii I, et al. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res. 1990;50:2290–5.
12. Aulino P, Berardi E, Cardillo V, Rizzuto E, Perniconi B, Ramina C, et al. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. BMC Cancer. 2010;10:363.
13. Taillandier D, Combaret L, Pouch MN, Samuels SE, Béchet D, Attaix D. The role of ubiquitin-proteasome-dependent proteolysis in the remodelling of skeletal muscle. Proc Nutr Soc. 2004;63:357–61.
14. Zhou X, Wang J, Lu J, Song Y, Kwak K, Jiao Q, et al. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell. 2010;142:531–43.
15. Lokireddy S, Wijesoma IW, Teng S, Bonala S, Gluckman PD, McFarlane C, et al. The ubiquitin ligase Mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli. Cell Metab. 2012;16:613–24.
16. Roberts B, Ahn B, Smuder A, Al-Rajhi M, Gill L, Beharry A, et al. Diaphragm and ventilatory dysfunction during cancer cachexia. FASEB J: Off Publ Fed Am Soc Exp Biol. 2013;27:2600–10.
17. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980;69:491–7.
18. American Cancer Society. Cancer facts & figures 2013. Atlanta: American Cancer Society; 2013.
19. Flurkey K, Currer JM, Harrison DE. The mouse in aging research. In: Fox JG, editor. The mouse in biomedical research. 2nd ed. Burlington, MA: American College of Laboratory Medicine (Elsevier); 2007. p. 637–72.
20. Sayer AA, Robinson SM, Patel HP, Shavlakadze T, Cooper C, Grounds MD. New horizons in the pathogenesis, diagnosis and management of sarcopenia. Age Ageing. 2013;42:145–50.
21. Conboy I, Conboy M, Wagers A, Girma E, Weissman I, Rando T. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005;433:760–4.
22. Chakkalakal J, Jones K, Basson M, Brack A. The aged niche disrupts muscle stem cell quiescence. Nature. 2012;490:355–60.
23. Cosgrove BD, Gilbert PM, Porpiglia E, Mourkioti F, Lee SP, Corbel SY, et al. Rejuvenation of the muscle stem cell population restores strength to injured aged muscles. Nat Med. 2014;20:255–64.
24. Bernet JD, Doles JD, Hall JK, Kelly Tanaka K, Carter TA, Olwin BB. p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice. Nat Med. 2014;20:265–71.
25. Di Marco S, Cammas A, Lian X, Kovacs E, Ma J, Hall D, et al. The translation inhibitor pateamine A prevents cachexia-induced muscle wasting in mice. Nature communications. 2012;3:896.
26. Penna F, Busquets S, Toledo M, Pin F, Massa D, Lopez-Soriano FJ, et al. Erythropoietin administration partially prevents adipose tissue loss in experimental cancer cachexia models. J Lipid Res. 2013;54:3045–51.
27. Zhang G, Jin B, Li YP. C/EBPbeta mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting. EMBO J. 2011;30:4323–35.
28. Bonetto A, Aydogdu T, Jin X, Zhang Z, Zhan R, Puzis L, et al. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. AJP: Endocrinol Metab. 2012;303:E410–21.